These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6117595)

  • 1. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance.
    Hirsch RL; Griffin DE; Winkelstein JA
    J Immunol; 1981 Nov; 127(5):1740-3. PubMed ID: 6117595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of complement depletion on the course of Sindbis virus infection in mice.
    Hirsch RL; Griffin DE; Winkelstein JA
    J Immunol; 1978 Oct; 121(4):1276-8. PubMed ID: 701795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement in viral infections. III. Activation of the classical and alternative complement pathways by Sindbis virus.
    Hirsch RL; Winkelstein JA; Griffin DE
    J Immunol; 1980 May; 124(5):2507-10. PubMed ID: 7365263
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural immunity to Sindbis virus is influenced by host tissue sialic acid content.
    Hirsch RL; Griffin DE; Winkelstein JA
    Proc Natl Acad Sci U S A; 1983 Jan; 80(2):548-50. PubMed ID: 6300853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the alternative complement pathway by enveloped viruses containing limited amounts of sialic acid.
    McSharry JJ; Pickering RJ; Caliguiri LA
    Virology; 1981 Oct; 114(2):507-15. PubMed ID: 6270885
    [No Abstract]   [Full Text] [Related]  

  • 6. Ability to activate the alternative complement pathway acquired by human and guinea-pig erythrocytes after contact with influenza virus.
    Lambré C; Thibon M
    Ann Immunol (Paris); 1980; 131C(2):213-21. PubMed ID: 7416718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
    Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
    J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation of the alternative complement pathway by normal and transformed cells in homologous and heterologous sera.
    McConnell I; Gorman NT; Raniwalla J; Powell P
    Eur J Immunol; 1981 Feb; 11(2):126-32. PubMed ID: 6260511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ; Joiner KA; Frank MM
    J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative pathway of complement activation by human lymphoblastoid B and T cell lines.
    Praz F; Lesavre P
    J Immunol; 1983 Sep; 131(3):1396-9. PubMed ID: 6604099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity.
    Hirsch RL; Wolinsky JS; Winkelstein JA
    Arch Virol; 1986; 87(3-4):181-90. PubMed ID: 3947239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid.
    Michalek MT; Mold C; Bremer EG
    J Immunol; 1988 Mar; 140(5):1588-94. PubMed ID: 3346543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An amino acid change in the exodomain of the E2 protein of Sindbis virus, which impairs the release of virus from chicken cells but not from mosquito cells.
    Li ML; Liao HJ; Simon LD; Stollar V
    Virology; 1999 Nov; 264(1):187-94. PubMed ID: 10544144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Auto-antibody dependent activation of the autologous classical complement pathway by guinea-pig red cells treated with influenza virus or neuraminidase: in vitro and in vivo study.
    Lambre CR; Thibon M; Le Maho S; Di Bella G
    Immunology; 1983 Jun; 49(2):311-9. PubMed ID: 6852870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Sindbis virus-induced pathology in mosquito and vertebrate cell cultures.
    Karpf AR; Brown DT
    Virology; 1998 Jan; 240(2):193-201. PubMed ID: 9454692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sindbis virus replication in vertebrate and mosquito cells: an interpretation.
    Schlesinger RW
    Med Biol; 1975 Oct; 53(5):295-301. PubMed ID: 1107684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement.
    Okada H; Tanaka H; Okada N
    Immunology; 1983 May; 49(1):29-35. PubMed ID: 6301976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation of Sindbis virus 26S mRNA does not require intact eukariotic initiation factor 4G.
    Castelló A; Sanz MA; Molina S; Carrasco L
    J Mol Biol; 2006 Feb; 355(5):942-56. PubMed ID: 16343528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restriction of a Sindbis virus mutant in BHK cells and relief of the restriction by the addition of adenosine.
    Lin YH; Simmonds HA; Stollar V
    Virology; 2002 Jan; 292(1):78-86. PubMed ID: 11878910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.